During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
2018 has seen extensive health-focused merger and partnership activity, with nearly 840 deals announced as of Q3. Players new to the industry are driving innovation in the traditionally cautious health and life sciences sectors, with unanticipated and innovative alliances poised to revolutionize health care. McDermott Will & Emery is at the forefront of this activity, helping progressive leaders redefine and navigate the health care landscape through Collaborative Transformations – game-changing partnerships that drive bold and creative business solutions.
To view the multimedia release go to:
https://www.multivu.com/players/English/8207752-mcdermott-innovative-partnership-business-collaborations/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
Is there such a thing as a nonsurgical facelift? Aesthetic plastic surgeons are conducting a panel discussion at The Aesthetic Meeting 2015, the annual meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), to determine whether a nonsurgical facelift is a legitimate cosmetic procedure. Surgeons discussed what constitutes a nonsurgical facelift and how it impacts the longitudinal care aesthetic plastic surgeons can provide to address facial aging.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310754-asaps-nonsurgical-facelift/
John Frieda® Hair Care invented the frizz-fighting category with Frizz Ease®, the game-changing hair smoother. Gina Rodriguez happens to be really gifted at taming her own naturally wavy, frizz-prone hair. So they’ve teamed up for a new movement – the #FrizzFreeHairGoals campaign – designed to teach women everything they need to know about styling any curl, wave or ringlet.
To kick off the partnership, Rodriguez will appear in a series of engaging how-to videos, to be posted on John Frieda’s social channels starting this month. In each one, the popular young actress tosses vanity out the window, talking openly about her biggest hair issue—frizz—and demonstrating easy ways to achieve the most beautiful, flattering styles of the moment.
“I’ve been a devotee of John Frieda® Frizz Ease® for years,” says Rodriguez. “Since my hair’s naturally wavy, I’ve spent more than my fair share of time fighting frizz. Frizz Ease® is the only thing that can help tame frizz and leave my hair looking smooth, so this partnership feels like a natural fit. I’m excited to have the chance to show women that they don’t have to suffer from frizzy hair forever — there’s a better way to style.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7811051-john-frieda-frizzfreehairgoals-gina-rodriguez/
May is Mental Health Awareness Month. Nine out of ten times when someone dies by suicide, they have a diagnosable mental health condition at the time of their death. However, mental health conditions are treatable, and most people who attempt suicide go on to live healthy productive lives.
Join the American Foundation for Suicide Prevention, the largest suicide prevention organization in the United States, in celebrating Mental Health Awareness Month. By drawing attention to the importance of mental health we hope to save lives and bring hope to those affected by suicide. Taking care of your mental health is the smart thing to do.
“Mental health is as important as physical health. It impacts the way we perceive, think, feel and behave in our daily lives,” said Dr. Christine Moutier, the chief medical officer of the American Foundation for Suicide Prevention. “To help us prevent suicide, there is a role for everyone, in every community. Don’t be afraid to have a caring conversation with someone if you notice troubling changes in their behavior. This conversation just might save their life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7824851-afsp-suicide-mental-health-awareness-month/
Inchirieri Auto Otopeni - servicii de inchirieri masini in Otopeni oferite de Promotor Rent a Car Bucuresti.
Promotor Rent a Car Otopeni este o companie autohtona care ofera servicii de inchirieri auto in Otopeni dar si in principalele orase din Romania: Bucuresti, Baneasa, Arad, Bacau, Brasov, Cluj, Constanta, Iasi, Timisoara, Suceava, Otopeni. Sibiu, Targu Mures.
Oferim o gama variata de masini de inchiriat noi in Otopeni, inchirieri auto ieftine cu toate taxele incluse: Tva, Asigurare Rca si Casco, Taxa de drum (Rovinieta) si Km nelimitati. Rezervati o masina de la Promotor Rent a Car Otopeni Bucuresti si veti putea sa o anulati oricand fara nicio taxa. Preturile pentru masinile inchiriate in Aeroportul Otopeni Bucuresti au toate taxele incluse si nu au alte taxe ascunse.
Promotor Rent a Car Bucuresti Otopeni ofera garantia unei calatorii placute in cele mai bune conditii de inchiriere. Constant oferim reduceri substantiale de pret pentru masinile de inchiriat in Otopeni dar si pentru serviciile de inchirieri auto in Bucuresti, atat pentru membrii nostri cat si pentru clentii noi.
Verifica acum oferta de pret pentru masinile de inchiriat din Aeroportul Otopeni si rezerva o masina de la Promotor Rent a Car Bucuresti fara nicio obligatie. Suntem aici pentru clientii nostri si ne dam silinta sa oferim conditii flexibile de inchiriere.
Pentru mai multe detalii va rugam sa vizitati site-ul Promotor Rent a Car https://www.auto-rent.ro si https://www.promotor-rentacar.ro sau ne puteti suna la 0734 403 403.
Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new Cardinal Health survey of hospital staff and decision makers. Despite respondents rating their supply chain processes as “good,” one in four hospital staff have seen or heard of expired product being used on a patient, and 18 percent have seen or heard of a patient being harmed due to a lack of necessary supplies.
On Saturday, May 21, 2016, Keep Memory Alive will host its extravagant 20th annual Power of Love™ gala at Las Vegas Arena honoring Tony Bennett with a spectacular 90th birthday celebration. True to its now-legendary style, the Power of Love gala will feature one-of-a-kind performances, exciting live auctions, remarkable wine and cocktails and exquisite cuisine by celebrity chef Wolfgang Puck. Now in its 20th year, the gala continues to raise funds in support of Cleveland Clinic Lou Ruvo Center for Brain Health.
Tony Bennett, who recently visited Cleveland Clinic Lou Ruvo Center for Brain Health commented, “During my tour of the Center, I saw first-hand the incredible care provided and ground-breaking initiatives in place, and I am honored to know that all proceeds from this 90th birthday event will benefit Keep Memory Alive and Cleveland Clinic Lou Ruvo Center for Brain Health.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7724851-keep-memory-alive-tony-bennett/
With the February launch of GOPO® Rosehip with Galactolipids, a natural, plant-based joint care supplement clinically proven to support joint health, the natural supplement is gaining traction and helping millions who suffer joint pain due to age, sports injuries, etc. Used extensively in Europe, GOPO is now available in the U.S. and proven effective in supporting long-term joint mobility and cartilage care.
GOPO Rosehip with Galactolipids is made from 100% specially-cultivated, natural rosehip using a patented extraction process and is the only product of its kind to contain a high level of galactolipids - a key component of the rosehip which may play a valuable role in the care of joints and joint tissues.
To view the multimedia release go to:
http://www.multivu.com/players/English/7918251-new-gopo-joint-care-all-natural-supplement/
In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness Day on October 13, MedImmune Specialty Care Division of AstraZeneca (NYSE: AZN) is launching the My+Story online resource center, which highlights the needs of women living with metastatic breast cancer and calls attention to metastatic disease as a key component of October’s National Breast Cancer Awareness Month. Metastatic Breast Cancer Awareness Day was officially recognized by the U.S. Congress in 2009, following a grassroots awareness effort led by members of the Metastatic Breast Cancer Network (MBCN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63080-astrazeneca-metastatic-breast-cancer-awareness
